Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1100 of 3284 entries
View as:

Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol)

Phase: N/A Priority: Normal
NCT ID: NCT05862545 Org: User:
Start: 06/01/23 End: 05/31/25 Due: 05/31/26

A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05057494 Org: User:
Start: 09/12/22 End: 04/10/29 Due: 04/10/30

A Study of MEDI-575 in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01102400 Org: User:
Start: 03/31/10 End: 11/30/12 Due: 11/30/13

A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or Suspected Asthma or COPD

Phase: N/A Priority: Normal
NCT ID: NCT06172777 Org: User:
Start: 01/29/24 End: 08/30/24 Due: 08/30/25

Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia

Phase: N/A Priority: Normal
NCT ID: NCT04997161 Org: User:
Start: 08/17/21 End: 11/17/21 Due: 11/17/22

Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04207775 Org: User:
Start: 03/30/20 End: 09/01/23 Due: 09/01/24

To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00944489 Org: User:
Start: 08/31/09 End: 01/31/10 Due: 01/31/11

Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

Phase: N/A Priority: Normal
NCT ID: NCT05872958 Org: User:
Start: 05/19/23 End: 08/20/24 Due: 08/20/25

Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03557307 Org: User:
Start: 08/01/18 End: 03/24/22 Due: 03/24/23

Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT02446912 Org: User:
Start: 06/09/15 End: 07/17/18 Due: 07/17/19

To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01403922 Org: User:
Start: 08/31/11 End: 08/31/12 Due: 08/31/13

Real-World Treatment Study of Koselugo (Selumetinib)

Phase: N/A Priority: Normal
NCT ID: NCT06360406 Org: User:
Start: 06/15/24 End: 09/30/31 Due: 09/30/32

Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01482884 Org: User:
Start: 03/31/12 End: 06/30/13 Due: 06/30/14

A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT06995820 Org: User:
Start: 06/06/25 End: 10/12/26 Due: 10/12/27

Effects of Rosuvastatin on Aortic Stenosis Progression

Phase: N/A Priority: Normal
NCT ID: NCT00800800 Org: User:
Start: 11/30/02 End: 09/30/08 Due: 09/30/09

Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT06995833 Org: User:
Start: 10/31/25 End: 06/29/29 Due: 06/29/30

Real World Evidence of Long-term Safety and Efficacy in Patients Treated With Durvalumab After Concurrent Chemoradiation for Unresectable Stage III NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03995875 Org: User:
Start: 07/25/19 End: 01/11/24 Due: 01/11/25

Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region

Phase: N/A Priority: Normal
NCT ID: NCT03082976 Org: User:
Start: 07/16/17 End: 07/24/19 Due: 07/24/20

A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00628758 Org: User:
Start: 12/31/05 End: 09/30/08 Due: 09/30/09

BRazilian Asthmatics Patients EOSinophilic Profile (BRAEOS)

Phase: N/A Priority: Normal
NCT ID: NCT03925415 Org: User:
Start: 01/24/19 End: 10/15/19 Due: 10/15/20

Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD5718 in Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03948451 Org: User:
Start: 04/30/19 End: 07/02/19 Due: 07/02/20

Magnetic Marker Monitoring (MMM) Study With Gel Matrix Tablets Under Fasting and Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01224587 Org: User:
Start: 10/31/10 End: 11/30/10 Due: 11/30/11

Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione

Phase: N/A Priority: Normal
NCT ID: NCT00729326 Org: User:
Start: 08/31/08 End: 10/31/09 Due: 10/31/10

Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00736788 Org: User:
Start: 08/31/08 End: 09/30/08 Due: 09/30/09

Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01280630 Org: User:
Start: 02/28/11 End: 05/31/11 Due: 05/31/12